How the new European regulation on medical devices will affect innovation

[1]  M. Torre,et al.  New medical device regulations: the regulator’s view , 2019, EFORT open reviews.

[2]  E. Caiani,et al.  The need for transparency of clinical evidence for medical devices in Europe , 2018, The Lancet.

[3]  N. Colombo,et al.  Building clinical trials around patients: Evaluation and comparison of decentralized and conventional site models in patients with low back pain , 2018, Contemporary clinical trials communications.

[4]  Z. Robaey,et al.  Safe-by-Design: from Safety to Responsibility , 2017, Nanoethics.

[5]  Travis G Maak,et al.  Medical Device Regulation: A Comparison of the United States and the European Union , 2016, The Journal of the American Academy of Orthopaedic Surgeons.

[6]  A. Kesselheim,et al.  Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study , 2016, British Medical Journal.

[7]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .

[8]  Ariel Dora Stern,et al.  Innovation Under Regulatory Uncertainty: Evidence from Medical Technology , 2014, Journal of public economics.

[9]  Amit G Singal,et al.  A Primer on Effectiveness and Efficacy Trials , 2014, Clinical and Translational Gastroenterology.

[10]  J. DiMasi,et al.  Competitiveness in follow-on drug R&D: a race or imitation? , 2011, Nature Reviews Drug Discovery.